Should you buy Clorox Company (The) (CLX)?
Updated
Clorox has a credible earnings beat track record and solid peer-relative standing, but the stock has run into a natural ceiling with less than 3% of room remaining to the consensus target, free cash flow conversion is critically weak at 8% of net income, and a confirmed downtrend with a death cross in place argues for patience rather than new exposure.
Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results.
Show full disclosure ▾Hide full disclosure ▴
About TrendMatrix. TrendMatrix is a publisher of general securities research and market commentary. We publish on a regular schedule. All content is the same for every subscriber in a tier — we do not provide personalized investment advice and we do not take into account any individual subscriber's financial situation, investment objectives, risk tolerance, tax situation, or holdings.
Not investment advice. TrendMatrix is not a registered investment adviser. Our content is for informational and educational purposes only. Consult your own licensed investment adviser, broker, or tax professional before making any investment decision.
Conflicts and positions. The TrendMatrix editorial team frequently holds personal long-term positions in securities discussed. We disclose positions held at the time of publication on each piece. We maintain a trading-window policy: we do not initiate or close positions in the same direction as a TrendMatrix publication within 24 hours before or 72 hours after publication.
No paid promotion. TrendMatrix does not accept payment from any issuer, broker, or third party in exchange for coverage of any security. Our sole compensation is subscription revenue.
No fiduciary duty. No fiduciary, advisory, or agency relationship is created between you and TrendMatrix by reading our content or subscribing to our service.
Performance. Past performance is not indicative of future results. Performance figures reflect the published model only and do not reflect any individual subscriber's actual results.
Engine methodology range
Range computation requires sufficient peer-comparable data; available for tickers with peer_count ≥3.
What the engine is tracking
| Pillar | Expectation | Trend |
|---|---|---|
Free cash flow represents only 8% of net income — a red-flag level of conversion that indicates reported earnings are not translating meaningfully into cash available for dividends or reinvestment, raising questions about the durability of shareholder returns. Quality breakdown | Free cash flow as a percentage of net income rises above 50% for two consecutive quarters, demonstrating that the gap between accounting earnings and cash generation is closing. | →Stable |
| CounterA temporary gap between earnings and cash flow can reflect timing differences in working capital or one-time capital deployment rather than a structural problem; if the gap closes naturally the concern resolves without any change to the underlying business model. | ||
The stock trades below its 200-day moving average with that average sloping down 3.6% over the past 30 days, a death cross confirmed, and on-balance volume in distribution — a technical posture that historically requires a sustained repair phase before a durable advance becomes possible. Momentum breakdown | The 50-day moving average crosses back above the 200-day moving average and the stock holds above both for 30 consecutive trading days, signaling a trend reversal. | →Stable |
| CounterConsumer staples stocks with reasonable quality profiles can form bottoms quickly when sentiment turns defensive; in a risk-off environment relative safety may attract buyers who compress the technical repair timeline significantly. | ||
With the stock just 2.9% below the near-term price ceiling and the risk/reward ratio at 0.47-to-1, the setup offers less than 50 cents of potential gain for every dollar at risk — a geometry that leaves almost no margin for error at current prices. Price targets | Analyst consensus price targets rise to above $110, restoring meaningful upside headroom and rebuilding a more compelling risk/reward ratio. | →Stable |
| CounterConsumer staples companies at or near targets can re-rate if analysts revise estimates upward on stronger-than-expected pricing power or volume recovery; the target ceiling is not permanent if earnings momentum improves. | ||
Free cash flow represents only 8% of net income — a red-flag level of conversion that indicates reported earnings are not translating meaningfully into cash available for dividends or reinvestment, raising questions about the durability of shareholder returns.
→Stable- Expectation
- Free cash flow as a percentage of net income rises above 50% for two consecutive quarters, demonstrating that the gap between accounting earnings and cash generation is closing.
CounterA temporary gap between earnings and cash flow can reflect timing differences in working capital or one-time capital deployment rather than a structural problem; if the gap closes naturally the concern resolves without any change to the underlying business model.
The stock trades below its 200-day moving average with that average sloping down 3.6% over the past 30 days, a death cross confirmed, and on-balance volume in distribution — a technical posture that historically requires a sustained repair phase before a durable advance becomes possible.
→Stable- Expectation
- The 50-day moving average crosses back above the 200-day moving average and the stock holds above both for 30 consecutive trading days, signaling a trend reversal.
CounterConsumer staples stocks with reasonable quality profiles can form bottoms quickly when sentiment turns defensive; in a risk-off environment relative safety may attract buyers who compress the technical repair timeline significantly.
With the stock just 2.9% below the near-term price ceiling and the risk/reward ratio at 0.47-to-1, the setup offers less than 50 cents of potential gain for every dollar at risk — a geometry that leaves almost no margin for error at current prices.
→Stable- Expectation
- Analyst consensus price targets rise to above $110, restoring meaningful upside headroom and rebuilding a more compelling risk/reward ratio.
CounterConsumer staples companies at or near targets can re-rate if analysts revise estimates upward on stronger-than-expected pricing power or volume recovery; the target ceiling is not permanent if earnings momentum improves.
▸ Show 1 more pillar▾ Show fewer
Three of the last four quarters produced positive earnings surprises — including a 29.8% beat at the oldest quarter and a 6.2% beat most recently — giving the company a credible delivery record despite one intervening miss, and the bull case explicitly highlights this beat pattern as a key positive.
→Stable- Expectation
- The company beats consensus estimates in three of the next four quarters with an average positive surprise above 5%, extending the track record across another full-year cycle.
CounterThe miss in the most recent February quarter (-3.0% surprise) shows the streak is not guaranteed; geographically concentrated supplier dependence could introduce input cost volatility that makes consistent delivery harder in subsequent periods.
→ Full pillar scorecard with all 4 pillars + per-dimension breakdown
When this thesis breaks
Falsifiable conditions per pillar — any one trip warrants review independent of price action. Engine-derived; not personalized advice.
Falsifying conditions — when triggered, the corresponding pillar's thesis is invalidated.
- P1Three of the last four quarters produced positive earnings surprises — including a 29.8% beat at the oldest quarter and a 6.2% beat most recently — giving the company a credible delivery record despite one intervening miss, and the bull case explicitly highlights this beat pattern as a key positive.
Trip ifEPS surprise falls below 0% for 2 consecutive quarters.
- P2Free cash flow represents only 8% of net income — a red-flag level of conversion that indicates reported earnings are not translating meaningfully into cash available for dividends or reinvestment, raising questions about the durability of shareholder returns.
Trip ifFree cash flow as a percentage of net income rises above 50% for 2 consecutive quarters.
- P3With the stock just 2.9% below the near-term price ceiling and the risk/reward ratio at 0.47-to-1, the setup offers less than 50 cents of potential gain for every dollar at risk — a geometry that leaves almost no margin for error at current prices.
Trip ifAnalyst consensus price target rises above $110, restoring more than 15% upside from current levels.
- P4The stock trades below its 200-day moving average with that average sloping down 3.6% over the past 30 days, a death cross confirmed, and on-balance volume in distribution — a technical posture that historically requires a sustained repair phase before a durable advance becomes possible.
Trip ifThe 50-day moving average crosses above the 200-day moving average and holds for 30 consecutive trading days.
How the engine reached this verdict
TrendMatrix's engine output for Clorox Company (The) (CLX) is SELL_IF_HOLDING with high conviction, score 5.0/10 at $95.87. The F-path SELL output reflects an overall score of 3.5 below the 5.6 soft trigger — multiple weakening dimensions accumulated rather than a single hard-floor breach. Asymmetry R:R of -0.08 is supplementary context, not the trigger.
The dominant failed gate is reward-to-risk (NEGATIVE) (with co-failures: death cross). SELL flips back toward HOLD if reward-to-risk recovers above its threshold AND a co-failing gate also clears. The strongest-cleared gate today is MOMENTUM:4.7>=4.5.
On the bull side: Strong earnings beat streak (3/4). On the bear side: Concentration risk — Geographic: U.S. markets (86.0%); Concentration risk — Supplier: sole source or single-source suppliers; Analyst target reached - limited upside remaining. Active engine warnings: V8: Target reached (-0.6% upside), V9 Gate Failed: ASYMMETRY:-0.1=NEGATIVE, V9 Gate Failed: DEATH_CROSS:HARD_BLOCK.
The engine's exit framework anchors to a tactical sell band near $95.87, with structural invalidation at $89.02. The asymmetric R:R against a reversal hypothesis is 0.52 — the upside scenario exists, but it requires multiple structural gates to flip; the downside scenario requires only one more disappointment. The engine's sizing output: 0.5% of portfolio at this asymmetry level (none-conviction tier).
For the full 10-dimension breakdown + V9 gate detail: Why TrendMatrix rates CLX — 10-dimension breakdown →
Bull case
- ▸Strong earnings beat streak (3/4)
Bear case
- ▸Concentration risk — Geographic: U.S. markets (86.0%)
- ▸Concentration risk — Supplier: sole source or single-source suppliers
- ▸Analyst target reached - limited upside remaining